[A case of two re-resections for peritoneal recurrence of pancreatic cancer].
A 63-year-old man underwent subtotal stomach-preserving pancreaticoduodenectomy and intraoperative radiation therapy for pancreatic head cancer (Stage IVa, JPS). Subsequently, he received adjuvant chemotherapy including gemcitabine (GEM). A peritoneal recurrence appeared adjacent to the right colon and the lower pole of the right kidney. He received chemotherapy including S-1 and GEM+S-1. Since the recurrent lesions were localized, he underwent resection for the recurrence lesions 2 years and 9 months after surgery. The resection was R1, and re-recurrence appeared in the lower pole of the right kidney. After chemotherapy and chemoradiotherapy, he underwent re-resection for the recurrence 4 years and 3 months after the first surgery. Three months after re-resection, multiple liver metastases appeared in the bilateral lobes. Reoperation can be one of the multidisciplinary management options for local recurrence of pancreatic cancer under specific conditions.
Dept. of Organ Regenerative Surgery, Fukushima Medical University.
Tomohiro
T
Kikuchi
Akira
A
Kenjo
Takashi
T
Kimura
Takayuki
T
Anazawa
Tetsu
T
Sato
Naoya
N
Sato
Junichiro
J
Haga
Junichiro
J
Watanabe
Takao
T
Tsuchiya
Takuro
T
Saito
Mitsukazu
M
Gotoh
D000970:Antineoplastic Agents / Q000627:therapeutic use; D003131:Combined Modality Therapy; D006801:Humans; D008297:Male; D008875:Middle Aged; D010190:Pancreatic Neoplasms / Q000473:pathology / Q000601:surgery* / Q000628:therapy; D016577:Pancreaticoduodenectomy; D010534:Peritoneal Neoplasms / Q000556:secondary / Q000601:surgery*; D012008:Recurrence
D000970:Antineoplastic Agents